WC
MDCO

Wexford Capital’s Medicines Co MDCO Stock Holding History

Wexford Capital’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-30,500
Closed -$1M – 161
2018
Q1 		$1M Buy
+30,500
New +$953K 0.07% 71
2016
Q3 		– Sell
-8,186
Closed -$275K – 191
2016
Q2 		$275K Hold
8,186
– – 0.05% 111
2016
Q1 		$260K Buy
+8,186
New +$267K 0.05% 96
2015
Q3 		– Sell
-16,700
Closed -$478K – 111
2015
Q2 		$478K Buy
+16,700
New +$465K 0.13% 60
2014
Q2 		– Sell
-188,030
Closed -$5.34M – 188
2014
Q1 		$5.34M Sell
188,030
-74,570
-28% -$2.47M 0.41% 32
2013
Q4 		$10.1M Sell
262,600
-193,900
-42% -$6.93M 0.87% 11
2013
Q3 		$15.3M Buy
456,500
+88,020
+24% +$2.8M 1.26% 8
2013
Q2 		$11.3M Buy
+368,480
New +$12.3M 0.99% 14

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Wexford Capital's MDCO Position: Q2 2018 in Review

Wexford Capital sold out of Medicines Co (MDCO) in Q2 2018, closing a stake of 30,500 shares — an estimated $1M sold.

Wexford Capital first reported a position in MDCO in Q2 2013 and held it in 8 quarters. The position peaked at $15.3M in Q3 2013. 188 funds tracked by Wall St. Rank hold MDCO as of Q2 2018.

  • Wexford Capital reported no remaining Medicines Co position as of Q2 2018 after selling out during the quarter.
  • Wexford Capital sold 30,500 Medicines Co shares in Q2 2018, an estimated $1M.
  • Wexford Capital first reported a position in Medicines Co in Q2 2013 and held it in 8 quarters.
  • Wexford Capital's Medicines Co position peaked at $15.3M in Q3 2013.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q2 2018.

Based on Wexford Capital's 13F filing for Q2 2018, filed 13 Aug 2018.